BioGENext Conference: Shaping the future of medicine through biomedical R&D

Kyiv, Ukraine

September 17-20, 2024

Omar O. Abudayyeh Dr., Co-Founder, Sherlock Biosciences, Abudayyeh-Gootenberg Laboratory, McGovern Institute for Brain Research at MIT, Assistant Professor at Harvard Medical School, USA

Janusz Bujnicki Prof., Head of the Laboratory of Bioinformatics and Protein Engineering at the International Institute of Molecular and Cell Biology in Warsaw, Poland

Jonathan Gootenberg Dr., Co-Founder, Sherlock Biosciences, Abudayyeh-Gootenberg Laboratory, McGovern Institute for Brain Research at MIT, USA

Ben Kleinstiver Dr., Kayden-Lambert MGH Research Scholar. Associate Investigator, Massachusetts General Hospital. Associate Professor, Harvard Medical School, Center for Genomic Medicine & Department of Pathology, USA

bioGENext2024-Plenary_Program.pdf

Nucleic-acid therapeutics: technologies and applications Development of DNA and RNA-based therapeutic solutions, technologies for their analytics, production and delivery approaches to selectively target and alter gene expression for potential treatment of complex diseases such as cancer, infections and genetic disorders.

Recombinant proteins and MAB development technologies Discovery, engineering and development of recombinant proteins and monoclonal antibodies to target specific molecular pathways, offering treatments for diseases, including cancer, autoimmune and metabolic disorders.

Gene editing technologies and applications in medicine Discovery and engineering of effectors and their delivery approaches for the development of gene editing technologies that enable targeted modifications to DNA/RNA sequences and offer potential for treatment of genetic disorders and personalized medicine approaches.

Computational biology and AI in biomedical research Integration of computer science and advanced AI frameworks to analyze biological data, enabling insights into complex biological systems for efficient drug discovery and personalized medicine development.

Biomarkers and molecular diagnostics Identification and validation of specific molecules or genetic markers characteristic for certain pathological or physiological processes, and their potential application as diagnostic tools for prognosis, and treatment decisions in medicine.

Other biomedical research Research activities focused on translating fundamental scientific discoveries into clinical applications, aiming to improve patient outcomes and advance medical practice.